Directory
>
Pam Howland
Pam Howland
Vice President, Portfolio and Program Management | Bolt Biotherapeutics, Inc.
Menlo Park, California, United States
Pam Howland
Summary
Pam Howland is a seasoned professional in the biopharmaceutical sector, currently serving as the Vice President of Portfolio and Program Management at Bolt Biotherapeutics. With a robust educational background that includes degrees from Stanford and Brown University, she possesses a strong foundation in applied mathematics and engineering management. Pam has extensive experience leading project teams and managing alliances across various organizations, including startups and established pharmaceutical companies. Her career reflects a commitment to advancing drug development and commercialization, leveraging her expertise in technology transfer and validation. Notably, she has held senior leadership roles at several prominent firms, showcasing her adaptability and strategic vision in the fast-paced biopharmaceutical landscape. Outside of her professional endeavors, Pam is likely to be passionate about mentoring the next generation of leaders in her field, given her extensive experience and leadership roles.
Pam Howland
Work Experience
Vice President, Portfolio and Program Management at
Bolt Biotherapeutics, Inc.
October 2022 - Present
Senior Director, Project Team Leader at
Lyell Immunopharma
May 2021 - October 2022
Vice President, Project and Alliance Management at
PellePharm
February 2021 - May 2021
Senior Director, Project and Alliance Management at
PellePharm
February 2020 - January 2021
Senior Director, Project Management at
PellePharm
February 2018 - January 2020
Executive Director, Program Management at
Sunesis Pharmaceuticals, Inc.
October 2012 - February 2018
Senior Director, Project Management at
Sunesis Pharmaceuticals, Inc.
October 2008 - October 2012
Senior Director, Project Management at
Jazz Pharmaceuticals
February 2008 - June 2008
Director, Project Management at
Jazz Pharmaceuticals
December 2005 - January 2008
Program Manager at
Cepheid
July 2001 - December 2005
Pam Howland
Education
Frequently Asked Questions about Pam Howland
What is Pam Howland email address?
Pam Howland's primary email address is ********@boltbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Pam Howland work for?
Pam Howland is a Vice President, Portfolio and Program Management at Bolt Biotherapeutics, Inc., a company specializing in Pharmaceutical preparations.
Where Pam Howland graduated from?
Pam Howland holds a degree in Applied Mathematics from Brown University.
How can I directly contact Pam Howland?
To contact Pam Howland directly, you can use the email address ********@boltbio.com. Complete contact information is available upon registration with Muraena.
Who is Pam Howland?
Pam Howland is a seasoned professional in the biopharmaceutical sector, currently serving as the Vice President of Portfolio and Program Management at Bolt Biotherapeutics. With a robust educational background that includes degrees from Stanford and Brown University, she possesses a strong foundation in applied mathematics and engineering management. Pam has extensive experience leading project teams and managing alliances across various organizations, including startups and established pharmaceutical companies. Her career reflects a commitment to advancing drug development and commercialization, leveraging her expertise in technology transfer and validation. Notably, she has held senior leadership roles at several prominent firms, showcasing her adaptability and strategic vision in the fast-paced biopharmaceutical landscape. Outside of her professional endeavors, Pam is likely to be passionate about mentoring the next generation of leaders in her field, given her extensive experience and leadership roles.
Pam`s contact details
********@boltbio.com
Colleagues
COO/CBO
Vice President of Biometrics
Scientific Co-founder & Senior Vice President, Research
Senior VP, Pharmaceutical Operations
VP of Finance, PAO
Vice President, Communications and Investor Relations
Senior Vice President Clinical Development
President & CEO